CSI Market
Sign In | Register

Pharmacyte Biotech Inc (PMCB) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access PMCB Annual Balance Sheets →
A period-by-period view of the balance sheet from Pharmacyte Biotech Inc to Apr 30 2025 helps clarify how Apr 30 2026's financial structure has changed over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Apr 30 2026)
(Jan 31 2026) (Oct 31 2025) (Jul 31 2025) (Apr 30 2025)
Assets
Cash & cash equivalent18.60
Marketable Securities, Current SH0.25
Cash & Short-term Investments18.00
Other Receivables0.24
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.10
Total Current Assets37.42
Intangible Assets0.00
Long-term investments0.00
Tax Assets, Noncurrent19.37
Other Assets, Noncurrent8.19
Warrant Asset Current-
Convertible Note Receivable Current-
Warrant Asset Femasys0.91
Total Assets46.75
Liabilities
Accounts Payable, Current AC0.27
Accrued Liabilities, Current AC0.52
Financial Instruments2.00
Other Liabilities, Current0.00
Total Current Liabilities0.83
Total Long-term Debt0.00
Derivative Liability, Noncurrent DE0.88
Other liabilities, Noncurrent8.11
Warrant Liabilities Noncurrent13.66
Total Liabilities11.77
Stockholders' Equity
Treasury Stock Common Value-45.01
Common Stock Value0.00
Additional Paid In Capital Common Stock182.72
Retained Earnings / Accumulated Deficit-104.39
Accumulated Other Comprehensive Income-0.02
Other Equity-0.02
Common Stockholder's Equity33.29
Total Stockholder's Equity33.29
Liabilities & Stockholder's Equity46.75
4 historic quarters locked

Sign in to unlock the full Pharmacyte Biotech Inc balance sheet history.

Sign In Create Free Account

About Pharmacyte Biotech Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001683168-26-001917

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.